Centene Corporation (NYSE:CNC) Q3 2021 Earnings Conference Call October 26, 2021 8:30 AM ET Company Participants Jen Gilligan - Senior Vice President, Finance and Investor Relations Michael Neidorff - Chairman and Chief Executive Officer Sarah London - Vice Chairman Drew Asher - Executive Vice President and Chief Financial Officer Kevin Counihan - Senior Vice President, Products Conference Call Participants Josh Raskin - Nephron Research Matt Borsch - BMO Capital Markets A.J. Rice - Credit Suisse Kevin Fisc ...

Acquisitions and Integrations - Centene Corporation is in the process of acquiring Magellan Health, which may impact future operating performance and market opportunities[6] - The company completed the acquisition of WellCare Health Plans, Inc., which is expected to enhance its service offerings and market presence[6] - There are risks associated with the Magellan Acquisition, including potential delays in regulatory approvals and the realization of expected synergies[7] - The integration of acquired businesses, such as Magellan Health, poses challenges that could affect operational efficiency and financial outcomes[15] Financial Performance - GAAP net earnings for the three months ended September 30, 2021, were $584 million, compared to $568 million for the same period in 2020, representing a 2.8% increase[18] - Adjusted net earnings for the nine months ended September 30, 2021, were $2.442 billion, down from $2.627 billion for the same period in 2020, reflecting a decrease of 7.0%[18] - GAAP diluted earnings per share (EPS) for the three months ended September 30, 2021, was $0.99, compared to $0.97 for the same period in 2020, an increase of 2.1%[18] - Adjusted diluted EPS for the nine months ended September 30, 2021, was $4.14, down from $4.56 for the same period in 2020, a decrease of 9.2%[18] - Selling, general and administrative expenses for the three months ended September 30, 2021, were $2.684 billion, compared to $2.507 billion for the same period in 2020, an increase of 7.1%[24] - The company reported acquisition-related expenses of $54 million for the three months ended September 30, 2021, down from $62 million for the same period in 2020, a decrease of 12.9%[18] - Legal settlement expenses for the three months ended September 30, 2021, amounted to $11 million, or $0.01 per diluted share[19] Market and Operational Risks - The company faces uncertainties related to COVID-19, which may affect healthcare costs and operational performance[7] - Centene's revenue and results of operations are influenced by risk-adjustment payment systems, which complicate financial forecasting[13] - The company derives a significant portion of its premium revenues from a limited number of states, making it vulnerable to regional economic changes[13] - Centene's business is subject to extensive regulations, and changes in laws could adversely impact its operations and financial condition[15] - Future performance is uncertain due to various risks, including competition and potential litigation related to acquisitions[9] Investments and Financial Instruments - The company had short-term investments of $1.5 billion and long-term investments of $14.7 billion as of September 30, 2021[237] - A hypothetical 1% increase in market interest rates would decrease the fair value of the company's fixed income investments by approximately $357 million[237] - The company has a foreign currency swap for a notional amount of $705 million to manage foreign exchange risk, with a potential decrease in fair value of approximately $7 million if the Great British Pound increases by 1% against the US Dollar[238] Non-GAAP Financial Measures - The company utilizes non-GAAP financial measures to provide a clearer view of its operational performance, which may differ from GAAP presentations[17]

Centene Corporation (NYSE:CNC) Q2 2021 Earnings Conference Call July 27, 2021 8:30 AM ET Company Participants Jennifer Gilligan - Investor Relations Michael Neidorff - Chairman, President and Chief Executive Officer Drew Asher - Executive Vice President and Chief Financial Officer Brent Layton - Executive Vice President and President, U.S. Health Plans, Products and International Kevin Counihan - Senior Vice President, Products Sarah London - President, Healthcare Enterprises and Executive Vice President, A ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ___________________________________________ FORM 10-Q ____________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ____________________________________________ | --- | --- | |--------- ...

Call Start: 08:30 January 1, 0000 9:22 AM ET Centene Corporation (NYSE:CNC) Q1 2021 Earnings Conference Call April 27, 2021 08:30 ET Company Participants Jennifer Gilligan - Senior Vice President, Finance & Investor Relations Michael Neidorff - Chairman, President & Chief Executive Officer Jeff Schwaneke - Executive Vice President & Chief Financial Officer Sarah London - Senior Vice President, Technology Innovation & Modernization Brent Layton - Executive Vice President Conference Call Participants Josh Ras ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ___________________________________________ FORM 10-Q ____________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to | --- | --- | |----------------------------------------------------- ...

Company Overview - Centene's total revenue for 2020 was $111.1 billion, a 49% increase[6,8] - The company had $26.3 billion in cash and investments as of December 31, 2020[6] - Centene added 10.3 million members, a 67% increase, between years[8] - The company operates in 50 states with government-sponsored healthcare programs and 3 international markets[7,9] - Centene covers over 25 million members, representing approximately 1 in 15 individuals in the United States[7] Strategic Initiatives - The company emphasizes a diversified growth strategy across markets, products, specialty services, and M&A[12] - Centene is focused on operational efficiencies to drive margin expansion[12] - The company is integrating Magellan to deepen whole health capabilities and strengthen its position in government-sponsored programs[10] Policy and Government Relations - The American Rescue Plan includes enhanced Marketplace APTCs, ensuring individuals pay no more than 8.5% of income for premiums in 2021 and 2022[14] - The American Rescue Plan provides a two-year 5 percentage point FMAP increase for states that newly expand Medicaid[14] - The American Rescue Plan provides $350 billion in state/local funding for COVID-19 relief[14]

Accelerating Medicines March 2021 Disclaimer . The following presentation has been prepared by Certara, Inc. ("we", "us", or "the Company") solely for informational purposes and should not be construed to be, directly or indirectly, in whole or in part, an offer to buy or sell and/or an invitation and/or a recommendation and/or a solicitation of an offer to buy or sell any security or instrument or to participate in any investment or trading strategy, nor shall any part of it form the basis of, or be relied ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31826 Centene Corporation (Exact name of registrant as specified in its charter) Delaware 42-1406317 (State or other jurisdiction of ...

Centene Corporation (NYSE:CNC) Q4 2020 Results Conference Call February 9, 2021 8:30 AM ET Company Participants Jennifer Gilligan - SVP, Finance and IR Michael Neidorff - Chairman, President and CEO Jeff Schwaneke - EVP and CFO Jon Dinesman - EVP, Government Relations Sarah London - SVP, Technology Innovation & Modernization Conference Call Participants Josh Raskin - Nephron Research Kevin Fischbeck - BOA A.J. Rice - Credit Suisse Justin Lake - Wolfe Research Matt Borsch - BMO Capital Markets Ricky Goldwass ...